The global peripheral neuropathy treatment market is estimated to grow at a CAGR of 4.3% during the forecast period. The increasing prevalence of diabetes and cancer and rising launches of generic versions of peripheral neuropathy drugs are some pivotal factors accelerating market growth. As per the International Diabetes Federation (IDF), in 2019, nearly 463 million […]